Biotechnology Analyst, CFA. Cancer, Autoimmune and Neurodegenerative Diseases. Audaces fortuna iuvat.
Texas
Joined April 2009
- Tweets8K
- Following577
- Followers1.6K
- Likes79
John Vandermosten retweeted
Lantern Pharma will be presenting at the @AACR annual meeting on April 19th, 9:00 am- 12:30pm ET. The presentation will focus on our drug candidate LP-184 and its unique mechanism of action, synthetic lethality. Check out the abstract here: bit.ly/3LjF3hU $LTRN
John Vandermosten retweeted
CEL-SCI Corporation $CVM Reports Third Quarter Fiscal 2022 Financial Results - businesswire.com/news/home/2…
John Vandermosten retweeted
We invite you to join our CEO, @GeertKersten1, on 7/14 at 12:30 PM ET as he returns to @reddit for a new #AMA to discuss $CVM, #Multikine and our recent presentations at @ASCO #ASCO22. Come ask him anything relevant!
reddit.com/r/IAmA/
John Vandermosten retweeted
Lantern Pharma's CEO @therealpanna is presenting at @theLDMicro Invitational on June 7th, 12PM PT. To watch his presentation in person or virtually register here: bit.ly/3xmDEQ5
John Vandermosten retweeted
MIMEDX issued a letter to our shareholders from Board Chair Dr. M. Kathleen Behrens. Read the full letter at votemimedx.com: bit.ly/3Gz1riO
John Vandermosten retweeted
MIMEDX was pleased to receive support from proxy advisory firm @GlassLewis FOR ALL its proposals. Read more about their recommendations here: bit.ly/3wxOd2D
John Vandermosten retweeted
BriaCell Adds Additional Clinical Sites to Broaden Patient Access and Further Boost Enrollment bit.ly/3sJgsZB
John Vandermosten retweeted
Our Key Opinion Leader panel discussion will begin in 1hr and there is still time to register! Join us to hear nicotine cessation experts discuss smoking & e-cigarette cessation. Click here to register:
us02web.zoom.us/webinar/regi…
#smokingcessation #quitsmoking
John Vandermosten retweeted
ProMIS $ARFXF Neurosciences Shareholders Approve Special Resolution
#alzheimersresearch #biotech #dementia #alzheimers #stockmarket #investors #traders #investing
John Vandermosten retweeted
Prof. Howard Weiner, Head of the SAC @TizianaLS had an interview on #BloombergMarkets where he spoke about #Foralumab and Tiziana's progress
bloomberg.com/news/videos/20…
#TLSA #tils #Bloomberg #interview
John Vandermosten retweeted
$MDXG reports better than expected revenues of $68.2 mm vs. our $61.3 mm up 27% y/y. Loss of 3c vs. our -2c estimate.
John Vandermosten retweeted
$CVM Shareholders, please vote. Too many of you have told me that your broker has not sent you your proxy or that you simply have not voted. Please ask for the proxy from your broker or call 877-870-8565 for help. We need your support every day.
John Vandermosten retweeted
$PMN.TO / $ARFXF / $BIIB: @ProMISinc @biogen - What In The Heck Is The FDA Thinking? - bit.ly/3gVyDVq by @vanjohn10
John Vandermosten retweeted
HIV Breakthrough at American Gene Technologies Gets Researchers Closer t... youtu.be/fiA2s7JCkJ8 via @YouTube
John Vandermosten retweeted
$Achv Announces Proposed Underwritten Public Offering
achievelifesciences.com/2021…
John Vandermosten retweeted
Did you know - 1 in 6 people across the globe are affected by neurological diseases?
$BTI's proprietary xB3 platform aims to revolutionize medicine and safely transport neurological treatments across the blood-brain barrier.
Learn more 👇
John Vandermosten retweeted
Join Gabriele from $TLSA for an exclusive chat hosted by @TCCtravel
Also speaking @wallstreetbets @Kevin_Soltani
bit.ly/3eCV6GS
$TLSA #wsb #Clubhouse #biotech
John Vandermosten retweeted
Shareholders have an important decision to make on May 27 and there are questions they should be asking about Prescience Point’s campaign. bit.ly/3h1TJmK
John Vandermosten retweeted
Don't miss our Fireside chat with B Riley in 5 minutes with Dr Shailubhai and Dr Weiner on:
webcaster4.com/Webcast/Page/…
#TLSA #Tils #BRiley #neuro